Myriad Genetics and the GeneSight Test

Support Psychiatric Nurses

What is the GeneSight test

The GeneSight Psychotropic Test from Myriad Genetics is the category-leading pharmacogenomic test for 62 medications commonly prescribed for depression, anxiety, ADHD, and other psychiatric conditions. The GeneSight Test can help inform clinicians about how a patient’s genes may impact how they metabolize and/or respond to certain psychiatric medications. It is designed to provide information that may help reduce the trial-and-error process that often takes place when patients are prescribed certain mental health medications.

Myriad Genetics and Psychiatric Nurses

Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Psychiatric nurses are a critical component in the treatment of depression, anxiety, ADHD and other disorders, with tens of thousands of clinicians ordering the GeneSight Test to help personalize treatment with mental health medications. The Myriad Mental Health Medical Affairs team is committed to supporting psychiatric nurses and their use of personalized medicine tools like the GeneSight Test by advancing the science and education of pharmacogenomics.

Educational resources for psychiatric nurses

The Myriad Mental Health Medical Affairs team is committed to educating psychiatric nurses on the use of personalized medicine tools like the GeneSight Test. To meet this mission, educational resources about test report interpretation, evidence for the clinical and economic utility, cost, and recent publications surrounding psychiatric pharmacogenomic testing are provided.

Recent publications related to psychiatric pharmacogenomic testing

Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder

Meta-analysis of Response and Remission Outcomes With a Weighted Multigene Pharmacogenomic Test for Adults with Depression

Real-World Impact of Pharmacogenomic Testion on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder

Continuing education for psychiatric nurses

Pharmacogenomic (PGx) testing has the potential to be a valuable tool in depression treatment decision-making for primary care providers and community psychiatric providers; however, clinicians may be uncertain of where PGx testing fits into the depression treatment algorithm, how to integrate results into their clinical decision making, and best practices in communicating with patients with major depressive disorder (MDD) regarding PGx testing. This series will educate the learner on what PGx testing can provide the clinician and how the results can be implemented for the benefit of their patients.

Medscape Pharmacogenomics Education Network (PEN)

Complimentary medical support is available for providers, patients, and caregivers

We’re here to help! Please contact our Medical Information Team.

Dr. Rachael Hart Earls

Dr. Rachael Hart Earls

PhD in Molecular Neuroscience

Medical Science Liaison Manager

Dr. Earls helps support pharmacogenomic education efforts, medical strategy, and evidence generation to advance the science of psychiatric pharmacogenomics.

GeneSight Mental Health Monitor

October 24, 2024

GeneSight® Mental Health Monitor: Special Election Series Phase III Update

The latest installment of the GeneSight Mental Health Monitor: Special Election Series, shows that as Election Day draws closer, Americans’ anxiety and/or depression around the 2024 Presidential Election remains significantly elevated.

Read moreInfographicsSpecial Election Report

October 24, 2024

Americans’ anxiety toward upcoming Presidential election has increased; mental health expert encourages treatment for those who are impacted

Phase II of GeneSight® Mental Health Monitor Election Survey from Myriad Genetics Shows 41% of Americans Report Feeling Anxious as the Election Draws Closer

Read moreInfographics

Hear from other healthcare providers

Tens of thousands of clinicians have ordered the GeneSight test for 3 million patients and counting. Explore what happens when the GeneSight test becomes part of a clinician’s practice through the testimonials shared below.

Johnny Williamson Headshot
Johnny Williamson

"I found GeneSight helps to build trust with my patients."

Read more

Nicole Dano Headshot
Nicole Dano

"I want to build a good relationship, a trusting relationship with my patient. So I trust GeneSight."

Read more

Whitnee Brown Headshot
Whitnee Brown

"The GeneSight testing has saved me an immense
amount of time."

Read more

    The stories shared on this page are individual healthcare providers’ personal experiences with GeneSight. Others may not have the same experience or outcome. Do not make any changes to your current medications or dosing without consulting your healthcare provider.

    Chat